Skip to main content
. 2014 Feb 4;306(7):E824–E837. doi: 10.1152/ajpendo.00175.2013

Fig. 3.

Fig. 3.

Expression of PPARα target genes after short-term PPARα agonist treatment. Sirt1F/F and Sirt1ΔLiv mice were treated with WY or fenofibrate for 5 days. RT-qPCR analysis was performed on liver samples, and values were normalized to β-actin and expressed as fold change from Sirt1F/F mice. Significant differences between control and WY or FF treatment are indicated (*P < 0.05). Significant differences between Sirt1F/F and Sirt1ΔLiv mice are indicated (†P < 0.05).